×
About 31,769 results

ALLMedicine™ Lymphomas Center

Research & Reviews  15,193 results

Two Clonally Distinct B-Cell Lymphomas Reveal the Diagnosis of XLP1 in a Male Child and...
https://doi.org/10.1097/MPH.0000000000002049
Journal of Pediatric Hematology/oncology; Iglesias Cardenas F, Agarwal AM et. al.

Jan 15th, 2021 - X-linked lymphoproliferative disease type 1 (XLP1) is a primary immunodeficiency disorder caused by pathogenic variants in the SH2D1A gene (SH2 domain containing protein 1A). Patients with XLP1 may present acutely with fulminant infectious mononuc...

Acute Brain Stroke Evolution Detected by 18F-FDG PET/CT and MRI Justifies the Discordan...
https://doi.org/10.1097/RLU.0000000000003486
Clinical Nuclear Medicine; Fernández-Rodríguez P, Tamayo Carabaño D et. al.

Jan 14th, 2021 - A 50-year-old man with angioimmunoblastic T-cell lymphoma in complete response to treatment presented new hypermetabolic brain lesions on 18F-FDG PET/CT suggestive of malignancy. These findings were correlated by MRI that showed cortical-subcortic...

Adoptive T-Cell Therapy for Epstein-Barr Virus-Related Lymphomas.
https://doi.org/10.1200/JCO.20.01709
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology; Heslop HE, Sharma S et. al.

Jan 12th, 2021 - Adoptive T-Cell Therapy for Epstein-Barr Virus-Related Lymphomas.|2021|Heslop HE,Sharma S,Rooney CM,|

Presentation of Diffuse Large B-Cell Lymphoma with Shoulder Pain: A Case Report.
https://doi.org/10.12659/AJCR.927828
The American Journal of Case Reports; Daliparty VM, Amoozgar B et. al.

Jan 12th, 2021 - BACKGROUND Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive lymphoid malignancy, which can present with an array of clinical features. DLBCL is notorious for having the highest rate of mortality in the developed areas of the world amo...

see more →

Guidelines  87 results

Off-the-Shelf CAR-T Cell Therapy ALLO-501 Induces High Responses in Relapsed/Refractory B-Cell Lymphomas
https://www.onclive.com/conference-coverage/asco-2020/off-the-shelf-cart-cell-therapy-allo501-induces-high-responses-in-relapsed-refractory-bcell-lymphomas

May 29th, 2020 - The allogeneic chimeric antigen receptor (CAR)-T cell therapy ALLO-501, paired with the monoclonal antibody ALLO-647, has clinical activity and a manageable safety profile in patients with relapsed/refractory large B-cell or follicular lymphoma. T...

Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and...
https://doi.org/10.1016/j.annonc.2019.10.010
Annals of Oncology : Official Journal of the European Society for Medical Oncology; Zucca E, Arcaini L et. al.

Jan 8th, 2020 - Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.|2020|Zucca E,Arcaini L,Buske C,Johnson PW,Ponzoni M,|diagnosis,epidemiology,therapy,

Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
https://www.sciencedirect.com/science/article/pii/S0923753419354651
Annals of Oncology; Zucca E,et al

Dec 31st, 2019 - This updated ESMO Clinical Practice Guideline provides key recommendations on the management of marginal zone lymphomas.

Diffuse Large B-Cell Lymphoma: ESMO Clinical Practice Guidelines
https://www.esmo.org/Guidelines/Haematological-Malignancies/Diffuse-Large-B-Cell-Lymphoma
Annals of Oncology; Tilly H et al

Nov 13th, 2019 - Diffuse large B-cell lymphoma is relatively common and represents 30%–58% of non-Hodgkin’s lymphomas. The updated ESMO Clinical Practice Guidelines provide information on the current management of diffuse large B-cell lymphoma including recommenda...

see more →

Drugs  81 results see all →

Clinicaltrials.gov  15,769 results

Two Clonally Distinct B-Cell Lymphomas Reveal the Diagnosis of XLP1 in a Male Child and...
https://doi.org/10.1097/MPH.0000000000002049
Journal of Pediatric Hematology/oncology; Iglesias Cardenas F, Agarwal AM et. al.

Jan 15th, 2021 - X-linked lymphoproliferative disease type 1 (XLP1) is a primary immunodeficiency disorder caused by pathogenic variants in the SH2D1A gene (SH2 domain containing protein 1A). Patients with XLP1 may present acutely with fulminant infectious mononuc...

Acute Brain Stroke Evolution Detected by 18F-FDG PET/CT and MRI Justifies the Discordan...
https://doi.org/10.1097/RLU.0000000000003486
Clinical Nuclear Medicine; Fernández-Rodríguez P, Tamayo Carabaño D et. al.

Jan 14th, 2021 - A 50-year-old man with angioimmunoblastic T-cell lymphoma in complete response to treatment presented new hypermetabolic brain lesions on 18F-FDG PET/CT suggestive of malignancy. These findings were correlated by MRI that showed cortical-subcortic...

Adoptive T-Cell Therapy for Epstein-Barr Virus-Related Lymphomas.
https://doi.org/10.1200/JCO.20.01709
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology; Heslop HE, Sharma S et. al.

Jan 12th, 2021 - Adoptive T-Cell Therapy for Epstein-Barr Virus-Related Lymphomas.|2021|Heslop HE,Sharma S,Rooney CM,|

Presentation of Diffuse Large B-Cell Lymphoma with Shoulder Pain: A Case Report.
https://doi.org/10.12659/AJCR.927828
The American Journal of Case Reports; Daliparty VM, Amoozgar B et. al.

Jan 12th, 2021 - BACKGROUND Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive lymphoid malignancy, which can present with an array of clinical features. DLBCL is notorious for having the highest rate of mortality in the developed areas of the world amo...

see more →

News  635 results

Allogeneic Transplant: Durable Remissions in T-Cell Lymphomas
https://www.medscape.com/viewarticle/942195

Dec 7th, 2020 - In patients with T-cell lymphoma, allogeneic transplant can lead to durable remissions among patients who might otherwise have poor outcomes, results of a large retrospective observational study suggest. Five-year progression-free survival (PFS) a...

Pigment Traits, Sun Sensitivity Tied to Risk for Blood Cancers
https://www.medscape.com/viewarticle/941593

Nov 24th, 2020 - Risk factors for keratinocyte carcinomas, primarily pigment traits and sun sensitivity, were associated with the risk of developing non-Hodgkin lymphomas (NHL) and chronic lymphocytic leukemia (CLL) in an analysis of 92,097 women in France. The pr...

Fast Five Quiz: Thyroid Cancer Practice Essentials
https://reference.medscape.com/viewarticle/938275

Sep 30th, 2020 - Although benign thyroid disease is relatively common, thyroid cancer occurs far less frequently. Most thyroid cancers are papillary carcinomas, with follicular carcinomas, medullary thyroid carcinomas, and anaplastic carcinomas accounting for far ...

Off-the-Shelf CAR-T Cell Therapy ALLO-501 Induces High Responses in Relapsed/Refractory B-Cell Lymphomas
https://www.onclive.com/conference-coverage/asco-2020/off-the-shelf-cart-cell-therapy-allo501-induces-high-responses-in-relapsed-refractory-bcell-lymphomas

May 29th, 2020 - The allogeneic chimeric antigen receptor (CAR)-T cell therapy ALLO-501, paired with the monoclonal antibody ALLO-647, has clinical activity and a manageable safety profile in patients with relapsed/refractory large B-cell or follicular lymphoma. T...

see more →

Patient Education  4 results see all →